| __timestamp | Soleno Therapeutics, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 2242216 | 1488000000 |
| Thursday, January 1, 2015 | 4536244 | 1525000000 |
| Friday, January 1, 2016 | 5184803 | 2111000000 |
| Sunday, January 1, 2017 | 3068742 | 1848000000 |
| Monday, January 1, 2018 | 7178000 | 1213000000 |
| Tuesday, January 1, 2019 | 16267000 | 1010000000 |
| Wednesday, January 1, 2020 | 23191000 | 997000000 |
| Friday, January 1, 2021 | 21453000 | 967000000 |
| Saturday, January 1, 2022 | 15265000 | 838000000 |
| Sunday, January 1, 2023 | 25189000 | 953000000 |
| Monday, January 1, 2024 | 998000000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Teva Pharmaceutical Industries Limited and Soleno Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Teva's R&D expenses have shown a downward trend, decreasing by approximately 36%, from a peak in 2016. This decline reflects Teva's strategic shift towards cost optimization amidst market challenges. In contrast, Soleno's R&D budget has surged by over 1,000% during the same period, highlighting its aggressive pursuit of new therapeutic solutions.
This divergence underscores the varied strategies within the pharmaceutical industry, where established giants like Teva focus on efficiency, while emerging players like Soleno invest heavily in innovation to carve out their niche.
Novo Nordisk A/S or Teva Pharmaceutical Industries Limited: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Amgen Inc. vs Soleno Therapeutics, Inc.
R&D Insights: How Teva Pharmaceutical Industries Limited and Neurocrine Biosciences, Inc. Allocate Funds
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and Axsome Therapeutics, Inc.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Corcept Therapeutics Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Viking Therapeutics, Inc.
R&D Insights: How Teva Pharmaceutical Industries Limited and Protagonist Therapeutics, Inc. Allocate Funds
Teva Pharmaceutical Industries Limited vs Novavax, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Genmab A/S vs Soleno Therapeutics, Inc.
R&D Spending Showdown: Soleno Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Soleno Therapeutics, Inc. and Xencor, Inc.